88 / 150
Guía OncoSur de diagnóstico y tratamiento del dolor
88
>
Bowles DW, O’Bryant CL, Camidge DR, et al. The intersection between cannabis and cancer in the United States.
Crit Rev Oncol Hematol. 2012;83:1.
Bruera E, Ripamonti C, Brenneis C, et al. A randomized double-blind crossover trial of intravenous lidocaine in the
treatment of neuropathic cancer pain. J Pain Symptom Manage. 1992;7:138-40.
Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized,
placebo-controlled trial. Neurology. 2003;60:1274-83.
Jackson K, Ashby M, Martin P, et al. “Burst” ketamine for refractory cancer pain: an open label audit of 39 patients.
J Pain Symptom Manage. 2001;22:834-42. Jones VM, Moore KA, Peterson DM. Capsaicin 8% topical patch
(Qutenza)-a review of the evidence. J Pain Palliat Care Pharmacother. 2011;25:32-41.
Haywood A, Good P, Khan S, et al. Corticosteroids for the management of cancer-related pain in adults. Cochrane
Database Syst Rev. 2015;4:CD010756.
Hill KP. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical
Review. JAMA. 2015;313:2474.
Johnson JR, Burnell-Nugent M, Lossignol D, et al. Multicenter, double-blind, randomized, placebo-controlled, par-
allel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with
intractable cancer-related pain. J Pain Symptom Manage. 2010;39:167.
Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin
J Pain. 2008;24:142.
Mercadante S, Fulfaro F, Casuccio A. The use of corticosteroids in home palliative care. Support Care Cancer.
2001;9:386-9.
Nurmikko TJ, Serpell MG, Hoggart B, et al. Sativex successfully treats neuropathic pain characterised by allodynia:
a randomised, double-blind, placebo-controlled clinical trial. Pain. 2007;133:210.
Lussier D, Portenoy RK. Adjuvant analgesics in pain management. En: Doyle D, Hanks G, Cherny N, et al., eds.
Oxford Textbook of Palliative Medicine. 3.ª ed. Oxford, England: Oxford University Press; 2003. p. 349-77.
Portenoy RK, Forbes K, Lussier D, et al. Difficult pain problems: an integrated approach. En: Doyle D, Hanks G,
Cherny N, et al., eds. Oxford Textbook of Palliative Medicine. 3.ª ed. Oxford, England: Oxford University Press;
2003. p. 438-58.
Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases
in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative
trial. Cancer J. 2001;7:377-87.
Russo EB, Guy GW, Robson PJ. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a can-
nabis-based medicine. Chem Biodivers. 2007;4:1729.
Sindrup SH, Bach FW, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized,
controlled trial. Neurology. 2003;60:1284.
Skrabek RQ, Galimova L, Ethans K, et al. Nabilone for the treatment of pain in fibromyalgia. J Pain. 2008;9:164.
Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis?
Randomised double blind placebo controlled crossover trial. BMJ. 2004;329:253.
Verdu B, Decosterd I, Buclin T, et al. Antidepressants for the treatment of chronic pain. Drugs. 2008;68:2611.
Wilsey B, Marcotte T, Deutsch R, et al. Low-dose vaporized cannabis significantly improves neuropathic pain.
J Pain. 2013;14:136.